PIKFYVE and cancer: In contrast, PIKFYVE inhibitors rapidly and reversibly disrupt lysosome homeostasis (microautophagy and chaperone-mediated autophagy), endosome trafficking (cellular homeostasis), and fusion of lysosomes with autophagosomes (macroautophagy), thereby effectively suppressing nutrient recovery and energy production in PIKFYVE-dependent cancer cells.